Lipid metabolic pathways as lung cancer therapeutic targets: a computational study.

about

Screening of feature genes of the ovarian cancer epithelia with DNA microarray Potential plasma lipid biomarkers in early-stage breast cancer.Inferences of individual drug responses across diverse cancer types using a novel competing endogenous RNA network.

P2860

Q34759643-C84CFEDF-66C6-4A7A-85C6-2E3AC0D06B19 Q46318107-731DB482-5D68-4CE4-BD8A-97D3499FC803 Q49719068-8710DA03-2B43-403E-AAED-B581676DB71F

P2860

Lipid metabolic pathways as lung cancer therapeutic targets: a computational study.

Item

http://www.wikidata.org/entity/Q42212895

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

Lipid metabolic pathways as lung cancer therapeutic targets: a computational study.

@en

Lipid metabolic pathways as lung cancer therapeutic targets: a computational study.

@nl

type

Item

label

Lipid metabolic pathways as lung cancer therapeutic targets: a computational study.

@en

Lipid metabolic pathways as lung cancer therapeutic targets: a computational study.

@nl

prefLabel

Lipid metabolic pathways as lung cancer therapeutic targets: a computational study.

@en

Lipid metabolic pathways as lung cancer therapeutic targets: a computational study.

@nl

P1476

Lipid metabolic pathways as lung cancer therapeutic targets: a computational study.

@en

P2093

Kojiro Yano

http://www.w3.org/2001/XMLSchema#string

P2860

Tumor BRCA1, RRM1 and RRM2 mRNA expression levels and clinical response to first-line gemcitabine plus docetaxel in non-small-cell lung cancer patients

MCM2--a promising marker for premalignant lesions of the lung: a cohort study

MET amplification occurs with or without T790M mutations in EGFR mutant lung tumors with acquired resistance to gefitinib or erlotinib

The orphan nuclear receptor LXRalpha is positively and negatively regulated by distinct products of mevalonate metabolism

DAVID: Database for Annotation, Visualization, and Integrated Discovery

Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources

Farnesyl transferase inhibitors block the farnesylation of CENP-E and CENP-F and alter the association of CENP-E with the microtubules

Transcriptional regulation of farnesyl pyrophosphate synthase by liver X receptors

Interactions between p300 and multiple NF-Y trimers govern cyclin B2 promoter function

Atorvastatin inhibits expression of minichromosome maintenance proteins in vascular smooth muscle cells

P304

519-529

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3892/IJMM.2011.876

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2011-12-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51974530

http://www.w3.org/2001/XMLSchema#string

P698

22211244

http://www.w3.org/2001/XMLSchema#string

P932

3573709

http://www.w3.org/2001/XMLSchema#string

Lipid metabolic pathways as lung cancer therapeutic targets: a computational study.

about

P2860

P2860

Lipid metabolic pathways as lung cancer therapeutic targets: a computational study.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P932